Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2026-01-06 @ 7:23 AM
Study NCT ID:
NCT00289159
Status:
UNKNOWN
Last Update Posted:
2006-02-09
First Post:
2006-02-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D009103', 'term': 'Multiple Sclerosis'}], 'ancestors': [{'id': 'D020278', 'term': 'Demyelinating Autoimmune Diseases, CNS'}, {'id': 'D020274', 'term': 'Autoimmune Diseases of the Nervous System'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D003711', 'term': 'Demyelinating Diseases'}, {'id': 'D001327', 'term': 'Autoimmune Diseases'}, {'id': 'D007154', 'term': 'Immune System Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'DEFINED_POPULATION'}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'ACTIVE_NOT_RECRUITING', 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2005-09', 'lastUpdateSubmitDate': '2006-02-08', 'studyFirstSubmitDate': '2006-02-08', 'studyFirstSubmitQcDate': '2006-02-08', 'lastUpdatePostDateStruct': {'date': '2006-02-09', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2006-02-09', 'type': 'ESTIMATED'}}, 'conditionsModule': {'keywords': ['aged 18-50', 'remitting evolution', 'less than two years of evolution', 'MS patients'], 'conditions': ['Multiple Sclerosis']}, 'descriptionModule': {'briefSummary': 'To determine wether multimodal MRI (conventinal T1 and T2 sequences, diffusion, magnetization transfer, spectroscopy) is reproducible; to follow up a cohort of patients with early remmittent MS after treatment with interferon.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '50 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n* MS patients according to Poser's criteria\n* Remitting evolution (less than two years of evolution)\n* Aged 18-50\n* Immunomodulatory treatment indicated\n\nExclusion Criteria:\n\n* Unable to perform MRI"}, 'identificationModule': {'nctId': 'NCT00289159', 'briefTitle': 'Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up', 'organization': {'class': 'OTHER', 'fullName': 'Groupe Hospitalier Pitie-Salpetriere'}, 'officialTitle': 'Follow Up by Multimodal MRI of a Cohort of Patients With Early Remitting Multiple Sclerosis (REPROMMS Study).', 'orgStudyIdInfo': {'id': 'RBM0110'}}, 'contactsLocationsModule': {'overallOfficials': [{'name': 'Ayman Tourbah, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Assistance Publique - Hôpitaux de Paris'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Groupe Hospitalier Pitie-Salpetriere', 'class': 'OTHER'}, 'collaborators': [{'name': 'Institut National de la Santé Et de la Recherche Médicale, France', 'class': 'OTHER_GOV'}]}}}